Bioengineering of bacteria for cancer immunotherapy.
Where this comes from
- Record sourced from PubMed, PMID 37322031.
- Also identified by DOI 10.1038/s41467-023-39224-8 and PMC identifier 10272223.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Here, we provide a brief overview of the approaches and strategies underlying bacteria-based cancer immunotherapy (BCiT). We also describe and summarize research in the field of synthetic biology, which aims to regulate bacterial growth and gene expression for immunotherapeutic use. Finally, we discuss the current clinical status and limitations of BCiT.
Medical subject headings
- Bioengineering
- Neoplasms